Lexaria Bioscience Corp. — Director's Dealing 2021

Sep 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lexaria Bioscience Corp. (LEXX)
CIK: 0001348362
Period of Report: 2021-09-01

Reporting Person: Carle Vanessa (Secretary)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-01	Stock Options	$6.23	A	10000	Acquired	2026-09-01	Common Shares (10000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
common shares	67	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants	$36	2024-11-13	Common Shares (67)	67	Direct
Stock Options	$5.31	2026-04-26	Common Shares (12500)	12567	Direct
Stock Options	$7.08	2026-06-08	Common Shares (5000)	17567	Direct